Top Story

Treat-and-extend AMD regimen sustains outcomes for up to 3 years

December 16, 2014

Read the Perspective from Andrew P. Schachat, MD

A treat-and-extend protocol improved vision and reduced retinal thickness for up to 3 years in patients with neovascular age-related macular degeneration, according to study findings.

The retrospective study included 212 eyes of 189 patients with treatment-naïve neovascular AMD treated with Lucentis 0.5 mg/0.05 mL (ranibizumab, Genentech) or Avastin 1.25 mg/0.05 mL (bevacizumab, Genentech) for at least 1 year under a treat-and-extend regimen.

Publication Exclusive

12-year-old girl experiences progressive vision loss and nyctalopia

December 15, 2014
A 12-year-old girl was referred to the New England Eye Center by an outside ophthalmologist for evaluation of decreased vision in both eyes.She was first noticed to have…

Surgical management of symptomatic vitreous floaters

December 12, 2014
Floaters are one of the most common presenting complaints in our retina clinics and perhaps in ophthalmology in general. Floaters not associated with retinal pathology…
In the Journals

Combination therapy may improve management of acute retinal necrosis

December 11, 2014
Patients treated with a combination systemic and intravitreal antiviral therapy for acute retinal necrosis may be more likely to have an improvement in visual acuity…
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
thumbnail for video 3918188829001

VIDEO: Multimodal imaging identifies specific ultrastructural characteristics

December 3, 2014
VIENNA, Austria — At the Advanced Retinal Therapy meeting here, Giuseppe Querques, MD, PhD, discussed the…
More »
In the JournalsPerspective

Treat-and-extend AMD regimen sustains outcomes for up to 3 years

December 16, 2014
A treat-and-extend protocol improved vision and reduced retinal thickness for up to 3 years in patients with neovascular age-related macular…
Publication Exclusive

12-year-old girl experiences progressive vision loss and nyctalopia

December 15, 2014
A 12-year-old girl was referred to the New England Eye Center by an outside ophthalmologist for evaluation of decreased vision in both eyes.She was…

Surgical management of symptomatic vitreous floaters

December 12, 2014
Floaters are one of the most common presenting complaints in our retina clinics and perhaps in ophthalmology in general. Floaters not associated with…
In the Journals

Combination therapy may improve management of acute retinal necrosis

December 11, 2014
Patients treated with a combination systemic and intravitreal antiviral therapy for acute retinal necrosis may be more likely to have an improvement…
In the Journals

Ocular nutritional supplements lack evidence in AREDS formula claims

December 10, 2014
An analysis of the top-selling brands of ocular nutritional supplements found they contain the same ingredients as in the AREDS and AREDS2 formulas…
thumbnail for video 3920137045001 Meeting News CoverageVideo

VIDEO: Vision for Mars program seeks to address vision problems for astronauts

December 9, 2014
NEW YORK – At the OSN New York meeting, John P. Berdahl, MD, discusses the ‘Vision for Mars’ initiative, which seeks to address…
In the Journals

Half-dose verteporfin PDT has positive outcomes in central serous chorioretinopathy

December 9, 2014
Half-dose verteporfin photodynamic therapy may be as effective as but safer than a full dose in treating patients with chronic central serous…
Meeting News Coverage

Konan introduces EvokeDx diagnostic platform

December 8, 2014
DENVER – Konan Medical announced the launch of EvokeDx, a next-generation visual pathway diagnostic platform, during a press conference here at…
In the Journals

Intravitreal ranibizumab yields long-term improvements in diabetic retinopathy severity

December 5, 2014
Patients who received intravitreal ranibizumab treatment alone showed better improvement in diabetic retinopathy severity than patients receiving…
Lee Jampol Meeting News Coverage

DRCR.net continues to deliver milestone results from multiple studies

December 3, 2014
VIENNA, Austria — The Diabetic Retinopathy Clinical Research Network (DRCR. net) continues to deliver positive results from clinical research…
More Headlines »
morganatic-roan morganatic-roan